Document is current
Any future updates will be listed below
-
Authors
Haycroft, Ebene R.
Davis, Samantha K.
Ramanathan, Pradhipa
Lopez, Ester
Purcell, Ruth A.
Tan, Li Lynn
Pymm, Phillip
Wines, Bruce D.
Hogarth, P. Mark
Wheatley, Adam K.
Juno, Jennifer A.
Redmond, Samuel J.
Gherardin, Nicholas A.
Godfrey, Dale I.
Tham, Wai-Hong
Selva, Kevin John
Kent, Stephen J.
Chung, Amy W. http://orcid.org/0000-0003-0020-9704
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (GNT2008092)
Medical Research Future Fund (GNT2002073)
Medical Research Future Fund (GNT2005544)
Howard Hughes Medical Institute (208693/Z/17/Z)
Australian Research Council (DE210100705)
University of Melbourne
- License Information
-
More Information
Article History
Received: 22 April 2023
Accepted: 26 June 2023
First Online: 21 July 2023
Declarations
:
: DIG and NAG declare that they have provisional patents submitted describing a SARS-CoV-2 RBD vaccine. The other authors have declared that no conflict of interest exists.
